Loading...
XHKG
1609
Oct 28, Last price  
54.45
1D
2.35%
1Q
-51.81%
Jan 2017
11,243.75%
IPO
7,907.35%
Name

Chong Kin Group Holdings Ltd

Chart & performance

D1W1MN
XHKG:1609 chart
P/E
—
P/S
—
EPS
2.50
Vol. 1Y
588.07%
Shs. 5Y
7.06%
Rev. 5Y
2.69%
Div Yld LY
—
Div Yld TTM
—
Revenues
403m
402,751,000
Net income
137m
136,970,000
CFO
157m
157,116,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Star Sports Medicine Co., Ltd. manufactures and markets clinical products and solutions for sports medicine in China. The company offers medical implant, such as bioabsorbable suture anchor, includes all-suture anchor, PEEK suture anchor, and carbon fiber reinforced PEEK suture anchor; interference screws and sheath fixation system, bioabsorbable interference screw, bioabsorbable interference screws and sheath fixation system, PEEK screws and sheath fixation system, and PEEK composite interference screw; suture buttons and high-strength sutures, such as adjustable suture button, fixed suture button, ultra-high molecular weight polyethylene(UHMWPE) suture; meniscus repair systems, all-suture meniscus repair system, accurFix all-inside meniscus repair system, and multi-needle and flexible meniscus repair system. The surgical equipment and associated medical consumables, includes plasma RF ablation equipment, arthroscopic surgical shaver, arthroscopic camera system, and disposable shaver blade plasma electrode. Its other products includes disposable PRP preparation kit, desktop centrifuge. The company also provides biomaterial platform, imaging and dynamic platform, intelligent medicine platform, and tissue engineering platform. The company was founded in 2017 and is headquartered in Beijing, China.

Key people

Wai Kwong Chau
Assistant General Manager - Projects · since 2015
Jack Yeung
Assistant General Manager - Administration · since 2015
Pik So Yu
Financial Controller · since 2018
Man Tim Cheung
Chief Executive Officer, Executive Director · since 2016
Chi Chung Fung
Executive Director · since 2016
Biao Ni
Executive Director · since 2018
Rui Yang
Executive Director · since 2019
Company Secretary · since 2018
Chairman of the Board, Chief Executive Officer · since 2018
Yifei Li
Non-Executive Independent Director · since 2018
Ping Kuen Tam
Non-Executive Independent Director · since 2018
Non-Executive Independent Director · since 2018
IPO date
Oct 17, 2016
Employees
16
Domiciled in
HK
Incorporated in
KY

Valuation

Title
HKD in thousands, except ratios and share amounts
FY
2025‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT